Post-parathyroidectomy serum phosphate kinetics is peculiar to female hemodialysis patients with a high body mass index

Journal of Nephrology

Volumn 19, Issue 1, 2006, Pages 70-76

  Lomonte, Carlo ^a   Vernaglione, Luigi ^b   Cazzato, Francesco ^a   Casucci, Francesco ^a   Chimienti, Domenico ^a   Bruno, Andrea ^a   Cocola, Savino ^a   Basile, Carlo ^a,c  

^a MIULLI GENERAL HOSPITAL   (Italy)

^b Hospital of Manduria   (Italy)

^c NONE   (Italy)

Author keywords

Body mass index; Female gender; Hemodialysis; Hyperparathyroidism; Parathyroidectomy; Phosphatemia

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; PARATHYROID HORMONE; PHOSPHATE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BODY BURDEN; BODY MASS; CALCIUM BLOOD LEVEL; CALCIUM MOBILIZATION; CAUCASIAN; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; HYPERPHOSPHATEMIA; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PATHOPHYSIOLOGY; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; RISK ASSESSMENT; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADULT; ANURIA; BIOLOGICAL MARKERS; BODY MASS INDEX; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM, SECONDARY; MALE; MIDDLE AGED; PARATHYROIDECTOMY; PHOSPHATES; POSTOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; SEX FACTORS;

EID: 33645471181     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ureña P, Basile C, Grateau G, Lacour B, Vassault A, Bourdeau A, Bourdon R, Dubost C, Zingraff J, Drüeke T. Short-term effects of parathyroidectomy on plasma biochemistry in chronic uremia. Kidney Int 1989; 36: 120-6.
2. Rodriguez M, Canalejo A, Garfia B, Aguilera E, Almaden Y. Pathogenesis of refractory secondary hyperparathyroidism. Kidney Int Suppl 2002; (80): S155-60.
3. Malberti F, Marcelli D, Conte F, Limido A, Spotti D, Locatelli F. Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study. J Am Soc Nephrol 2001; 12: 1242-8.
4. Basile C, Lomonte C, Vernaglione L, Casucci F, Chimienti D, Bruno A, Cocola S, Antonicelli Verrelli E, Cazzato F. A high body mass index and female gender are associated with an increased risk of nodular hyperplasia of parathyroid glands in chronic uraemia. Nephrol Dial Transplant 2005; [Epub ahead of print].
5. Lomonte C, Cazzato F, Casucci F, Chimienti D, Bruno A, Cocola S, Antonicelli Verrelli E, Basile C. Female hemodialysis patients have an increased risk of nodular hyperplasia of parathyroid glands. J Nephrol 2005; 18: 92-5.
6. Casino FG, Basile C, Gaudiano V, Lopez T. A modified algorithm of the single pool urea kinetic model. Nephrol Dial Transplant 1990; 5: 214-9.
7. Kazama JJ, Sato F, Omori K, Hama H, Yamamoto S, Maruyama H, Narita I, Gejyo F, Yamashita T, Fukumoto S, Fukagawa M. Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients. Kidney Int 2005; 67: 1120-5.
8. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42 (suppl 3): S1-201.
9. Indridason OS, Pieper CF, Quarles LD. Predictors of short-term changes in serum parathyroid hormone levels in hemodialysis patients: role of phosphorus, calcium and gender. J Clin Endocrinol Metab 1998; 83: 3860-6.
10. Gupta A, Kallenbach LR, Zasuwa G, Divine GW. Race is a major determinant of secondary hyperparathyroidism in uremic patients. J Am Soc Nephrol 2000; 11: 330-4.
11. Almaden Y, Felsenfeld AJ, Rodriguez M, Canadillas S, Luque F, Bas A, Bravo J, Torregrosa V, Palma A, Ramos B, Sanchez C, Martin-Malo A, Canalejo A. Proliferation in hyperplastic human and normal rat parathyroid glands: role of phosphate, calcitriol, and gender. Kidney Int 2003; 64: 2311-7.
12. Foley RN, Li S, Liu J, Gilbertson DT, Chen S-C, Collins AJ. The fall and rise of parathyroidectomy in US hemodialysis patients, 1992 to 2002. J Am Soc Nephrol 2005; 16: 210-8.
13. Naveh-Many T, Almogi G, Livni N, Silver J. Estrogen receptors and biologic response in rat parathyroid tissue and C cells. J Clin Invest 1992; 90: 2434-8.
14. Taal MW, Masud T, Green D, Cassidy MJ. Risk factors for reduced bone density in haemodialysis patients. Nephrol Dial Transplant 1999; 14: 1922-8.
15. Pazianas M, Phillips ME, MacRae KD, Eastwood JB. Identification of risk factors for radiographic hyperparathyroidism in 422 patients with end-stage renal disease: development of a clinical predictive index. Nephrol Dial Transplant 1992; 7: 1098-105.
16. Spalding EM, Chamney PW, Farrington K. Phosphate kinetics during hemodialysis: evidence for biphasic regulation. Kidney Int 2002; 61: 655-67.
17. 2-microglobulin and phosphate during hemodialysis: effects of treatment frequency and duration. Semin Dial 2005; 18: 401-8.
18. Prié D, Beck L, Ureña P, Friedlander G. Recent findings in phosphate homeostasis. Curr Opin Nephrol Hypertens 2005; 14: 318-24.
19. Sato T, Tominaga Y, Ueki T, Goto N, Matsuoka S, Katayama A, Haba T, Uchida K, Nakanishi S, Kazama JJ, Gejyo F, Yamashita T, Fukagawa M. Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism. Am J Kidney Dis 2004; 44: 481-7.